Jianping Chen

922 total citations
20 papers, 451 citations indexed

About

Jianping Chen is a scholar working on Oncology, Molecular Biology and Immunology. According to data from OpenAlex, Jianping Chen has authored 20 papers receiving a total of 451 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Oncology, 5 papers in Molecular Biology and 5 papers in Immunology. Recurrent topics in Jianping Chen's work include Immunotherapy and Immune Responses (4 papers), Cancer Immunotherapy and Biomarkers (3 papers) and Immune Cell Function and Interaction (3 papers). Jianping Chen is often cited by papers focused on Immunotherapy and Immune Responses (4 papers), Cancer Immunotherapy and Biomarkers (3 papers) and Immune Cell Function and Interaction (3 papers). Jianping Chen collaborates with scholars based in China, Hong Kong and United States. Jianping Chen's co-authors include Cailu Song, Xiaoping Liu, Ning Li, Xiaoming Xie, Feng Ye, Lu Yang, Xinhua Xie, Yanan Kong, Neng Wang and Hailin Tang and has published in prestigious journals such as Trends in Pharmacological Sciences, Cell Death and Differentiation and British Journal of Pharmacology.

In The Last Decade

Jianping Chen

19 papers receiving 443 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jianping Chen China 11 253 205 82 68 50 20 451
Tzu-Tang Wei Taiwan 11 307 1.2× 188 0.9× 104 1.3× 102 1.5× 58 1.2× 20 491
Kanae Echizen Japan 11 280 1.1× 147 0.7× 147 1.8× 111 1.6× 55 1.1× 14 544
Chang-Hai Tsai Taiwan 7 198 0.8× 106 0.5× 55 0.7× 23 0.3× 51 1.0× 8 334
Michele Pietrafesa Italy 11 269 1.1× 105 0.5× 79 1.0× 34 0.5× 77 1.5× 17 448
Shuping Xu United States 13 304 1.2× 105 0.5× 96 1.2× 49 0.7× 79 1.6× 18 467
Jiali Yang China 13 174 0.7× 114 0.6× 83 1.0× 46 0.7× 62 1.2× 40 407
Jara Majuelos‐Melguizo Spain 6 291 1.2× 206 1.0× 55 0.7× 38 0.6× 23 0.5× 10 457
Virginie Quidville France 8 228 0.9× 88 0.4× 129 1.6× 42 0.6× 44 0.9× 10 398
Guiqin Hou China 14 414 1.6× 77 0.4× 100 1.2× 47 0.7× 70 1.4× 24 539

Countries citing papers authored by Jianping Chen

Since Specialization
Citations

This map shows the geographic impact of Jianping Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jianping Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jianping Chen more than expected).

Fields of papers citing papers by Jianping Chen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jianping Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jianping Chen. The network helps show where Jianping Chen may publish in the future.

Co-authorship network of co-authors of Jianping Chen

This figure shows the co-authorship network connecting the top 25 collaborators of Jianping Chen. A scholar is included among the top collaborators of Jianping Chen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jianping Chen. Jianping Chen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Shen, Ke, Xinhuai Dong, Chong Zeng, et al.. (2025). B3GNT3 is an oncogenic and prognostic biomarker in human tumors via pan-cancer analysis combined with experimental validation. Translational Cancer Research. 14(9). 5181–5198.
2.
Chen, Xi, Zhiwei Zou, Qianli Wang, et al.. (2022). Inhibition of NOS1 promotes the interferon response of melanoma cells. Journal of Translational Medicine. 20(1). 205–205. 7 indexed citations
3.
Zhang, Yin, Yuping Xu, Jing Sun, et al.. (2021). Mitomycin C Inhibits Esophageal Fibrosis by Regulating Cell Apoptosis and Autophagy via lncRNA-ATB and miR-200b. Frontiers in Molecular Biosciences. 8. 8 indexed citations
4.
Qian, Qian, et al.. (2020). Relationship between IL10 and PD‐L1 in Liver Hepatocellular Carcinoma Tissue and Cell Lines. BioMed Research International. 2020(1). 8910183–8910183. 12 indexed citations
5.
Qian, Qian, et al.. (2020). Relationship between IL-10 and PD-L1 in esophageal carcinoma tissues and IL-10 down-regulates PD-L1 expression via Met signaling pathway. Journal of Gastrointestinal Oncology. 11(2). 337–355. 11 indexed citations
6.
7.
Yang, Jing, Yu Chen, Weifeng Tang, et al.. (2019). Investigation of ICOS, CD28 and CD80 polymorphisms with the risk of hepatocellular carcinoma: a case–control study in eastern Chinese population. Bioscience Reports. 39(7). 6 indexed citations
8.
Hao, Xianglin, Fei Han, Ning Zhang, et al.. (2018). TC2N, a novel oncogene, accelerates tumor progression by suppressing p53 signaling pathway in lung cancer. Cell Death and Differentiation. 26(7). 1235–1250. 38 indexed citations
9.
Xu, Zhenyu, Jing Shen, Maggie Haitian Wang, et al.. (2016). Comprehensive molecular profiling of the B7 family of immune-regulatory ligands in breast cancer. OncoImmunology. 5(8). e1207841–e1207841. 36 indexed citations
10.
You, Jieshu, Jianping Chen, Jessie S. M. Chan, et al.. (2016). Effect of YH0618 soup on chemotherapy-induced toxicity in patients with cancer who have completed chemotherapy: study protocol for a randomized controlled trial. Trials. 17(1). 354–354. 4 indexed citations
11.
12.
He, Wei, et al.. (2015). Geranylgeranylacetone attenuates hepatic fibrosis by increasing the expression of heat shock protein 70. Molecular Medicine Reports. 12(4). 4895–4900. 15 indexed citations
13.
Yang, Lu, Hailin Tang, Yanan Kong, et al.. (2015). LGR5 Promotes Breast Cancer Progression and Maintains Stem-Like Cells Through Activation of Wnt/β-Catenin Signaling. Stem Cells. 33(10). 2913–2924. 134 indexed citations
14.
Chen, Jianping, Jing Yang, Jingting Jiang, Yun Zhuang, & Wei He. (2014). Function and subsets of dendritic cells and natural killer cells were decreased in gastric cancer.. PubMed. 7(11). 8304–11. 21 indexed citations
15.
He, Wei, et al.. (2012). Berberine Inhibits Growth and Induces G1 Arrest and Apoptosis in Human Cholangiocarcinoma QBC939 Cells. Journal of Pharmacological Sciences. 119(4). 341–348. 42 indexed citations
16.
Broeck, Bianca Van, Jianping Chen, Maria Desmidt, et al.. (2011). Chronic treatment with a novel γ‐secretase modulator, JNJ‐40418677, inhibits amyloid plaque formation in a mouse model of Alzheimer's disease. British Journal of Pharmacology. 163(2). 375–389. 45 indexed citations
17.
Fernández, Ariel, et al.. (2008). Taming the induced folding of drug-targeted kinases. Trends in Pharmacological Sciences. 30(2). 66–71. 9 indexed citations
18.
Shen, Aiguo, Min Ji, Lei Liu, et al.. (2008). The Role of β-1,4-Galactosyltransferase-I in the Skin Wound-healing Process. American Journal of Dermatopathology. 30(1). 10–15. 5 indexed citations
19.
Chen, Jianping, Melissa Smith, Kenneth Kolinsky, et al.. (2006). Antitumor activity of HER1/EGFR tyrosine kinase inhibitor erlotinib, alone and in combination with CPT-11 (irinotecan) in human colorectal cancer xenograft models. Cancer Chemotherapy and Pharmacology. 59(5). 651–659. 21 indexed citations
20.
Nielsen, Loretta L., Bin Shi, Gerald Hajian, et al.. (1999). Combination therapy with the farnesyl protein transferase inhibitor SCH66336 and SCH58500 (p53 adenovirus) in preclinical cancer models.. PubMed. 59(23). 5896–901. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Tzu-Tang Wei Breakdown of academic impact, for papers by Kanae Echizen Breakdown of academic impact, for papers by Chang-Hai Tsai Breakdown of academic impact, for papers by Michele Pietrafesa Breakdown of academic impact, for papers by Shuping Xu Breakdown of academic impact, for papers by Jiali Yang Breakdown of academic impact, for papers by Jara Majuelos‐Melguizo Breakdown of academic impact, for papers by Virginie Quidville Breakdown of academic impact, for papers by Guiqin Hou
Rankless by CCL
2026